Related Experiment Video
Updated: Jul 11, 2026

An Optimized Protocol for Candida albicans Infection in Schmidtea mediterranea to Study Fungal Pathogenesis and Host Defense
Published on: April 17, 2026
Use of the PATH Alliance database to measure adherence to IDSA guidelines for the therapy of candidemia
D Horn1, D Neofytos, J Fishman
1Division of Infectious Diseases, Thomas Jefferson University Hospital, 211 South 9th Street, Philadelphia, PA 19107, USA. david.horn@jefferson.edu
Abstract:
Candidemia is an increasing complication of the care of complex patients. Adherence to Infectious Diseases Society of America (IDSA) guidelines for the treatment of candidemia was investigated to assess the impact of compliance on outcomes of therapy. Data on the epidemiology, diagnosis, and treatment of patients with invasive fungal infections (IFIs) was extracted from the PATH Alliance registry, a prospective, multicenter, observational database of invasive fungal infections. Patients with proven candidemia were evaluated for adherence to the IDSA guidelines in terms of choice, dosage, and duration of antifungal therapy. Removal of central venous catheters and time to treatment initiation were assessed. Four-week survival data were compared. Of the 418 patients with candidemia who were included in the study, 361 patients with the necessary data sets were identified, of whom 262 (72.6%) were treated within the IDSA guidelines for the treatment of candidemia (IDSA group); the remaining 99 (27.4%) patients received treatment different from the guidelines (non-IDSA group). Kaplan-Meier (KM) survival analysis for patients in the IDSA and non-IDSA group showed mortality rates of 21.9 and 13.6%, respectively; the difference between the two groups was not statistically significant (P = 0.093). Following the exclusion of patients requiring mechanical ventilation or acute cardiac support, the modified survival KM curves were similar between the two groups. Significantly more patients in the IDSA group required mechanical ventilation and tunneled central catheters, had a concomitant IFI, and received caspofungin. The duration of treatment and inappropriate dosing did not appear to have had a significant impact on survival. Most of the deviations from IDSA guidelines were due to the inappropriate duration and dosing of therapy. No significant difference in mortality was noted between the IDSA and non-IDSA groups. The basis of these differences merit further study.
Insights
Adherence to Infectious Diseases Society of America (IDSA) guidelines for candidemia treatment did not significantly impact patient survival. Deviations in treatment duration and dosage were common but did not affect mortality rates in this study.
Area of Science:
- Infectious Diseases
- Clinical Medicine
- Epidemiology
Background:
- Candidemia is a growing concern in complex patient care.
- Assessing adherence to established treatment guidelines is crucial for optimizing patient outcomes.
Purpose of the Study:
- To evaluate the impact of adherence to Infectious Diseases Society of America (IDSA) guidelines on candidemia treatment outcomes.
- To analyze survival rates in patients treated according to IDSA guidelines versus those receiving non-standard therapy.
Main Methods:
- Data from 361 patients with candidemia were extracted from the PATH Alliance registry.
- Patients were categorized into IDSA guideline-adherent (n=262) and non-adherent (n=99) groups.
- Kaplan-Meier survival analysis was used to compare 4-week mortality rates.
Main Results:
- 72.6% of patients received treatment adhering to IDSA guidelines.
- Mortality rates were 21.9% in the IDSA group and 13.6% in the non-IDSA group (P=0.093).
- No statistically significant difference in survival was observed between the groups, even after adjusting for mechanical ventilation or cardiac support.
Conclusions:
- Adherence to IDSA guidelines for candidemia treatment did not demonstrate a significant impact on 4-week survival in this cohort.
- Deviations from guidelines, primarily in treatment duration and dosing, were observed but did not significantly alter mortality.
- Further research is warranted to understand the factors influencing these outcomes and refine treatment strategies.
Related Concept Videos
Automated Microbial Diagnostics
Candidiasis
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Antimicrobial Effectiveness
